Evidence for p53 as guardian of the cardiomyocyte mitochondrial genome following acute adriamycin treatment

Journal of Histochemistry and Cytochemistry

Volumn 55, Issue 6, 2007, Pages 629-639

  Nithipongvanitch, Ramaneeya ^a,b   Ittarat, Wanida ^b   Velez, Joyce M ^c   Zhao, Rui ^a   St Clair, Daret K ^c   Oberley, Terry D ^a,d  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF KENTUCKY   (United States)

^d WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

Author keywords

Apoptosis; Cardiomyopathy; Doxorubicin; Mitochondrial DNA; Oxidative stress

Indexed keywords

CYTOCHROME C; DOXORUBICIN; MITOCHONDRIAL DNA; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOSOL; DNA DAMAGE; DNA REPAIR; GENOME; HEART MUSCLE CELL; IMMUNOGOLD LABELING; KNOCKOUT MOUSE; MALE; MITOCHONDRION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; STRUCTURE ANALYSIS; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CYTOCHROMES C; DEOXYGUANOSINE; DNA DAMAGE; DNA, MITOCHONDRIAL; DOXORUBICIN; GENOTYPE; HCT116 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; MICROSCOPY, IMMUNOELECTRON; MITOCHONDRIA, HEART; MODELS, BIOLOGICAL; MUTATION; MYOCYTES, CARDIAC; OXIDATION-REDUCTION; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 34249029995     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.6A7146.2007     Document Type: Article

References (44)

1. Achanta G, Sasaki R, Feng L, Carew JS, Lu W, Pelicano H, Keating MJ, et al. (2005) Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma. EMBO J 24:3482-3492
2. Akatsuka S, Aung TT, Dutta KK, Jiang L, Lee WH, Liu YT, Onuki J, et al. (2006) Contrasting genome-wide distribution of 8-hydroxyguanine and acrolein-modified adenine during oxidative stress-induced renal carcinogenesis. Am J Pathol 169:1328-1342
3. Caelles C, Helmberg A, Karin M (1994) p53-depenclcnt apoptosis in the absence of transcriptional activation of p53-target genes. Nature 370:220-223
4. Chaiswing L, Cole MP, St. Clair DK, lttarat W, Szwecla LI, Oberley TD (2004) Oxidative damage precedes nitrative damage in adriamycin-induced cardiac mitochondrial injury. Toxicol Pathol 32:536-547
5. Chen D, Yu Z, Zhu Z, Lopez CD (2006) The p53 pathway promotes efficient mitochondrial DNA base excision repair in colorectal cancer cells. Cancer Res 66:3485-3494
6. Childs AC, Phaneuf SL, Dirks AJ, Phillips T, Leeuwenburgh C (2002) Doxorubicin treatment in vivo caused cytochrome c release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutasc activity, and Bcl-2:Bax ratio. Cancer Res 62:4592-4598
7. Chipuk JE, Bouchier-Hayes L, Kuwana T, Newmeyer DD, Green DR (2005) PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science 309:1732-1735
8. de Souza-Pinto NC, Harris CC, Bohr VA (2004) p53 functions in the incorporation step in DNA base excision repair in mouse liver mitochondria. Oncogene 23:6559-6568
9. Erster S, Moll UM (2005) Stress-induced p53 runs a transcription- independent death program. Biochem Biophys Res Commim 331: 843-850
10. Haupt Y, Rowan S, Shaulian E, Vousden KH, Oren M (1995) Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes Dev 9:2170-2183
11. Heyne K, Mannebach S, Wuertz E, Knaup KX, Mabyar Roemer M, Roemer K (2004) Identification of a putative p53 binding sequence within the human mitochondrial genome. FEBS Lett 578:198-202
12. Humbel BM, Sibon OC, Stierhof YD, Schwarz H (1995) Ultra-small gold particles and silver enhancement as a detection system in immunolabeling and in situ hybridization experiments. J Histochem Cytochem 43:735-737
13. Kang D, Hamasaki N (2002) Maintenance of mitochondrial DNA integrity: repair and degradation. Curr Genet 41:311-322
14. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Branson RT, Weinberg RA (1994) Tumor spectrum analysis in p53-mutant mice. Curr Biol 4:1-7
15. Jeffers J, Parganas E, Lee Y, Yang C, Wang J, Brennan J, MacLean K, et al. (2003) Puma is an essential mediator of p53-dependent and -independent apoptotic pathway. Cancer Cell 4:321-328
16. Lebrecht D, Kokkori A, Ketelsen UP, Setzer B, Walker UA (2005) Tissue-specific mtDNA lesions and radical-associated mitochondrial dysfunction in human hearts exposed to doxorubicin. J Pathol 207:436-444
17. Lien TC, Lin SM, Nithipongvanitch R, Oberley TD, Noel T, Zhao Q, Daosukho C, et al. (2006) Tumor necrosis factor receptor deficiency exacerbated Adriamycin-induced cardiomyocytes apoptosis: an insight into the Fas connection. Mol Cancer Ther 5:261-269
18. Liu FT, Newland AC, Jia L (2003) Bax conformation change is a crucial step for PUMA-mediated apoptosis in human leukemia. Biochem Biophys Res Commun 310:956-962
19. Liu X, Chua CC, Gao J, Chen Z, Landy Cathy LC, Hamdy R, Chua Balvin HL (2004) Pifithrin-α protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice. Am J Physiol Heart Circ Physiol 286:H933-939
20. Long X, Boluyt MO, Hipolito ML, Lundberg MS, Zheng JS, O'Neill L, Cirielli C, et al. (1997) p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes. J Clin Invest 99: 2635-2643
21. Lotem J, Peled-Kamar M, Groner Y, Sachs L (1996) Cellular oxidative stress and the control of apoptosis by wild-type p53, cytotoxic compounds, and cytokines. Proc Natl Acad Sci USA 93:9166-9171
22. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, et al. (1994) p53 status and the efficacy of cancer therapy in vivo. Science 266:807-810
23. Lucocq JM, Habermann A, Watt S, Backer JM, Mayhew TM, Griffiths G (2004) A rapid method for assessing the distribution of gold labeling on thin sections. J Histochem Cytochem 52:991-1000
24. Mahyar-Roemer M, Fritzsche C, Wagner S, Wagner S, Laue M, Roemer K (2004) Mitochondrial p53 levels parallel total p53 levels independent of stress response in human colorectal carcinoma and glioblastoma cells. Oncogene 23:6226-6236
25. Marcelino LA, Thilly WG (1999) Mitochondrial mutagenesis in human cells and tissues. Mutat Res 434:177-203
26. Marchenko ND, Zaika A, Moll UM (2000) Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J Biol Chem 275:16202-16212
27. Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, Hurley PJ, et al. (2006) p53 regulates mitochondrial respiration. Science 312:1650-1653
28. Matsuo S, Toyokuni S, Osaka M, Hamazaki S, Sugiyama T (1995) Degradation of DNA in dried tissues bv atmospheric oxygen. Biochem Biophys Res Commun 208:1021-1027
29. Mayhew TM, Griffiths G, Lucocq JM (2004) Applications of an efficient method for comparing immunogold labelling patterns in the same sets of compartments in different groups of cells. Histochem Cell Biol 122:171-177
30. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P, Moll UM (2003) p53 has a direct apoptogenic role at the mitochondria. Mol Cell 11:577-590
31. Miyashita T, Reed JC (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293-299
32. Nakano K, Vousden KH (2001) PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7:683-694
33. Oberley TD (2002) Ultrastructural localization and relative quantification of 4-hydroxynonenal-modified proteins in tissues and cell compartments. Methods Enzymol 352:373-377
34. Ogihara M, Tanno M, Izumiyama N, Nakamura H, Taguchi T (2002) Increase in DNA polymerase γ in the hearts of adriamycin-administered rats. Exp Mol Pathol 73:234-241
35. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, et al. (1997) Apoptosis in failing human heart. N Engl J Med 336:1131-1141
36. Park BS, Song YS, Yee SB, Lee BG, Seo SY, Park YC, Kim JM, et al. (2005) Phospho-ser 15-p53 translocates into mitochondria and interacts with Bcl-2 and Bcl-xL in eugenol-induced apoptosis. Apoptosis 10:193-200
37. Shizukuda Y, Matoba S, Mian OY, Nguyen T, Hwang PM (2005) Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice. Mol Cell Biochem 273:25-32
38. Song H, Conte JV Jr, Foster AH, McLaughlin JS, Wei C (1999) Increased p53 protein expression in human failing myocardium. J Heart Lung Transplant 18:744-749
39. Terman A, Brunk UT (2004) Myocyte aging and mitochondrial turnover. Exp Gerontol 39:701-705
40. Toyokuni S, Tanaka T, Llattori Y, Nishiyama Y, Yoshida A, Uchida K, Lliai H, et al. (1997) Quantitative immunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest 76:365-374
41. von Harsdorf R, Li PF, Dietz R (1999) Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation 99:2934-2941
42. Wencker D, Chandra M, Nguyen K, Miao W, Garantziotis S, Factor SM, Shirani J, et al. (2003) A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest 111:1497-1504
43. Wu S, Ko YS, Teng MS, Ko YL, Hsu LA, Hsueh C, Chou YY, et al. (2002) Adriamycin-induced cardiomyocyte and endothelial cell apoptosis: in vitro and in vivo studies. J Mol Cell Cardiol 34: 1595-1607
44. Zhao Y, Chaiswing L, Velez JM, Batinic-Haberle I, Colburn NH, Oberley TD, St. Clair DK (2005) p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase. Cancer Res 65:3745-3750